← All diseases Cancer

Prostate cancer (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of highest quality only (136)Meta-analysis (28)Treatment guideline (1)Randomized trial (67)Systematic review (20)Phase 3 study (20)Clinical trial (632)Review article (236)Early study (phase 1 or 2) (38)Single patient description (132)Laboratory or animal study (27)Commentary or editorial (29)Retracted publication (3) Studies currently seeking participants only (40)

Filter

Publications (1468)

• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of first-line treatments for metastatic castration-resistant prostate cancer based on phase II and III randomized controlled trials: A PROSTA-MAP systematic review and network meta-analysis. (2026/02/05) ♡
• Studies on the functionality of the TC-NER ERCC6-M1097V protein variant frequently found in Louisiana patients with PCa upon UV damage. (2026/02/03) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Efficacy and safety of triple or dual therapies for metastatic hormone-sensitive prostate cancer: a systematic review and Bayesian network meta-analysis. (2026/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Added Value of Interim FDG PET/CT in Resolving PSA-PSMA Discordance during PSMA-targeted Radioligand Therapy. (2026/02/01) ♡
• 68Ga-PSMA-11 PET/CT Versus Conventional Imaging for Response Evaluation in Metastatic Castration-resistant Prostate Cancer: A Single-center Prospective Study. (2026/02/01) ♡
• Association of Fat and Muscle Mass With Overall Survival in Patients With Metastatic Prostate Cancer Treated With Enzalutamide, Abiraterone, and Docetaxel. (2026/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. National Reporting of Bowel Cancer Care by the National Bowel Cancer Audit (NBOCA) Supports Hospital Teams to Improve care and Outcomes. (2026/02/01) ♡
• Clinical Characteristics Associated with High [(68)Ga]Ga-PSMA-11 Uptake and Preliminary Therapeutic Outcomes in Patients with Metastatic Adenoid Cystic Carcinoma. (2026/02/01) ♡
• PSMA PET-directed radiotherapy for prostate cancer: From precision planning to future innovations. (2026/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Mortality from cancer in Tunisia in 2020 and death certification quality. (2026/02/01) ♡
• Evaluation of the Approach to Rectal Injuries During Pelvic Uro-Oncological Surgery. (2026/01/29) ♡
• Diet-Microbiome Relationships in Prostate-Cancer Survivors with Prior Androgen Deprivation-Therapy Exposure and Previous Exercise Intervention Enrollment. (2026/01/21) ♡
• Unveiling the hidden cardiovascular risk of sipuleucel-T: a pharmacovigilance analysis using the FDA Adverse Event Reporting System, 2010-2025. (2026/01/20) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Central Nervous System Lymphoma With Testicular and Prostatic Involvement: A Case Report. (2026/01/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lung cancer immunotherapy in 2025: where we stand and what comes next? (2026/01/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. IL-6/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities. (2026/01/15) ♡
• Nursing-led multidisciplinary ERAS collaboration improves early recovery after laparoscopic radical prostatectomy for localized prostate cancer: a retrospective cohort study. (2026/01/14) ♡
• Diagnostic value of plasma heat shock protein 90α and inflammatory markers in prostate cancer. (2026/01/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. (161)Tb-PSMA radioligand therapy in prostate cancer: current evidence and future perspectives. (2026/01/14) ♡
• Feasibility and Implementation of INTERVAL-GAP4: A Global Randomised Controlled Trial of Intense Hybrid-supervised/Self-managed Versus Self-directed Exercise for Metastatic Prostate Cancer. (2026/01/07) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Fracture risk and survival outcomes of radium-223 therapy for bone metastases in mCRPC and the modulatory role of bone-protective therapy: a systematic review and meta-analysis. (2026/01/05) ♡
• Association between platelet-to-lymphocyte ratio and high risk for prostate cancer among middle-aged and older US men. (2026/01/02) ♡
• Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types. (2026/01/01) ♡
• Analysis of overall survival in patients with second primary malignancies following with the first diagnosis of nonmetastatic prostate cancer: A study utilizing the Surveillance, Epidemiology, and End Results database. (2026/01/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Bioequivalence and Food Effect Assessment of Apalutamide Tablets Relative to Erleada in Healthy Chinese Male Participants. (2026/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Gut-Prostate Axis: Decoding the Interplay of Environmental Factors, Microbial Metabolites, and Hormonal Regulation in Prostate Cancer Pathogenesis. (2026/01/01) ♡
• Deep learning-based predictive models for assessing the impact of clinical factors and second primary malignancy on survival in patients with colorectal cancer. (2025/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T. (2025/12/31) ♡
• PARP Inhibitor Olaparib and Its Combination Therapy in Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Network Meta-analysis. (2025/12/31) ♡
• A 24-Year Analysis of Percutaneous Renal Biopsy Trends in Australia. (2025/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diagnosis of Prostate Cancer via Transanal Endoscopic Ultrasound-Guided Fine-Needle Biopsy in a Patient With Bone Lesions and a Rapid Clinical Response to Enzalutamide Plus Degarelix. (2025/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Twelve mutations, three trials, and five different labels: PARP inhibitors regulatory inconsistencies in prostate cancers. (2025/12/30) ♡
• Comparison of Prostate-Specific Antigen Response in Black Patients with Metastatic Castration-Sensitive Prostate Cancer Initiated on Apalutamide vs Abiraterone Acetate. (2025/12/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Gut Microbiome in Oncogenesis and Oncotherapies. (2025/12/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anticancer Mechanisms of Bioactive Compounds from Sweet Potato (Ipomoea batatas L.) Leaves: A Systematic Review. (2025/12/29) ♡
• TMPO promotes cellular dissemination and metastasis in circulating tumor cells. (2025/12/27) ♡
• Survivin recombinant overlapping peptide (ROP) vaccine in advanced solid tumours: a first-in-human, multicentre, open-label, phase 1a dose-escalation study. (2025/12/27) ♡
• Prostate Cancer Disparities Between Public and Private Healthcare Patients in Tasmania, a Regional State of Australia. (2025/12/26) ♡
• Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes. (2025/12/26) ♡
• Prevalence and Clinical Associations of Germline DDR Variants in Prostate Cancer: Real-World Evidence from a 122-Patient Turkish Cohort. (2025/12/26) ♡
• Anatomical Refinement of Pelvic Lymphadenectomy in Extraperitoneal Radical Prostatectomy Based on a Constant Venous Landmark. (2025/12/25) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Clinical and functional outcome of salvage vesiculectomy for local prostate cancer recurrence: a single-arm meta-analysis. (2025/12/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neoadjuvant Therapies for Prostate Cancer-Current Paradigms and Future Directions. (2025/12/24) ♡
• Prediction of Bone Metastasis in Prostate Cancer Using Blood Glucose-6-Phosphate Dehydrogenase Activity: A Retrospective Medical Record Review. (2025/12/23) ♡
• Assessment of Local and Metastatic Recurrence Following Robot-Assisted Radical Prostatectomy by Margin Status Using PSMA PET/CT Scan. (2025/12/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Isolated hilar mass mimicking cholangiocarcinoma as a rare metastatic manifestation of recurrent colorectal cancer: A case report. (2025/12/22) ♡
• Observational Management for Patients with Biochemical Recurrence Following Radical Prostatectomy, in the Absence of Detectable Disease on Restaging PSMA PET/CT Imaging. (2025/12/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Two Cases of Neuroendocrine Transformation of Prostate Carcinoma in the Era of Expanding Therapeutic Options: Do the Increased Number of Available Treatments Translate Into Improved Patient Outcomes? (2025/12/22) ♡
• Global burden and trends analysis of common cancers attributable to dietary risks from 1990 to 2021 and projection to 2050: a secondary analysis for the global burden of disease study 2021. (2025/12/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review. (2025/12/19) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.